Literature DB >> 29182449

Gender interaction of uric acid in the development of hypertension.

Shinichiro Nishio1, Yukio Maruyama1, Naoki Sugano1, Tatsuo Hosoya2, Takashi Yokoo1, Satoru Kuriyama1,3.   

Abstract

AIM: The present study explored the gender interaction on the risk of uric acid in the new development of hypertension. STUDY
DESIGN: A longitudinal retrospective cohort. SUBJECTS &
METHODS: A total of 5,807 individuals with an average age of 38 ± 7 years old were recruited. Individuals whose blood pressure rose more than 140/90mmHg or those who newly commenced antihypertensive treatment were defined as a new onset of hypertension. Cox regression analysis was employed for the analysis.
RESULTS: During the 10-years follow-up, 42.8% of men and 22.2% of women had developed hypertension. Factors to predict the hypertension development were male gender, older age, higher BMI, higher uric acid, and higher mean blood pressure. An association between higher uric acid levels and higher incidence of hypertension remained statistically significant in women in a multivariate model adjusted for various clinical variables (Hazard ration (HR), 1.180; 95%CI, 1.018 to 1.369), whereas such association was not found in men (HR, 1.034; 95%CI, 0.994 to 1.075). The interaction between the two genders reached statistical significance (p for interaction = 0.007).
CONCLUSION: Higher uric acid is associated with the incident hypertension in the both genders. Women are more susceptible to the development of hypertension than men.

Entities:  

Keywords:  Uric acid; cohort; gender; hypertension; risk factor

Mesh:

Substances:

Year:  2017        PMID: 29182449     DOI: 10.1080/10641963.2017.1392556

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 1064-1963            Impact factor:   1.749


  6 in total

1.  Serum uric acid level is associated with an increase in systolic blood pressure over time in female subjects: Linear mixed-effects model analyses.

Authors:  Kazuma Mori; Masato Furuhashi; Marenao Tanaka; Yukimura Higashiura; Masayuki Koyama; Nagisa Hanawa; Hirofumi Ohnishi
Journal:  Hypertens Res       Date:  2021-11-30       Impact factor: 3.872

2.  Mediation of the effect of serum uric acid on the risk of developing hypertension: a population-based cohort study.

Authors:  Zhi Cao; Yangyang Cheng; Shu Li; Hongxi Yang; Li Sun; Ying Gao; Pei Yu; Weidong Li; Yaogang Wang
Journal:  J Transl Med       Date:  2019-06-18       Impact factor: 5.531

3.  Gender- and Age-Specific Differences in the Association of Hyperuricemia and Hypertension: A Cross-Sectional Study.

Authors:  Xiaoyun Lin; Xiqian Wang; Xin Li; Lili Song; Zhaowei Meng; Qing Yang; Wenjuan Zhang; Yuxia Gao; Zhenwen Yang; Heng Cai; Bo Bian; Yongle Li; Xuefang Yu; Xin Du; Shaopeng Xu; Jing Nie; Ming Liu; Jinhong Sun; Qing Zhang; Ying Gao; Kun Song; Xing Wang; Li Zhao; Yaguang Fan
Journal:  Int J Endocrinol       Date:  2019-02-28       Impact factor: 3.257

Review 4.  Uric Acid and Hypertension: Prognostic Role and Guide for Treatment.

Authors:  Federica Piani; Arrigo F G Cicero; Claudio Borghi
Journal:  J Clin Med       Date:  2021-01-24       Impact factor: 4.241

Review 5.  Sex, Allergic Diseases and Omalizumab.

Authors:  Maria Maddalena Sirufo; Francesca De Pietro; Lia Ginaldi; Massimo De Martinis
Journal:  Biomedicines       Date:  2022-01-29

6.  Association of serum uric acid, morning home blood pressure and cardiovascular risk factors in a population with previous prehypertension: a cross-sectional study.

Authors:  Lucky Aziza Bawazier; Mochammad Sja'bani; Fredie Irijanto; Zulaela Zulaela; Agus Widiatmoko; Abdul Kholiq; Yasuhiko Tomino
Journal:  BMJ Open       Date:  2020-09-09       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.